Аnna A. Shishova

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev et al. · Emerging Microbes & Infections · 2021 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence

Nadezhda V. Yagovkina, K. A. Subbotina, Andrey A. Tsaan et al. · Frontiers in Immunology · 2022 · 39 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles

Dmitry Bagrov, Andrey Moiseenko, Maria G. Karlova et al. · Microscopy Research and Technique · 2021 · 27 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance

Maria A Prostova, Anatoly P. Gmyl, Denis V. Bakhmutov et al. · RNA Biology · 2015 · 16 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

Ilya Gordeychuk, Liubov I. Kozlovskaya, Nadezhda V. Yagovkina et al. · Viruses · 2023 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17